Drug intelligence / Profile preview

arnica

Development stage
Phase 3
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Arnica is a perennial herb most commonly referring to the species *Arnica montana*, but also includes related species such as *Arnica chamissonis* and others. It has been widely used in folk and homeopathic medicine for conditions like bruises, sprains, muscle pain (myalgia), joint pain (arthralgia), inflammation and wound healing[2][4][7]. The primary active constituents are sesquiterpene lactones which have anti-inflammatory properties. Mechanistically these compounds inhibit binding of transcription factors AP-1 and NF-κB to DNA—key regulators of inflammatory gene expression—and suppress matrix metalloproteinases MMP1 and MMP13 involved in cartilage destruction[8]. Topical preparations are considered the safest form; oral use is associated with significant toxicity risks including gastroenteritis and cardiac effects[2][5]. There is some evidence that topical arnica gel may reduce pain from osteoarthritis comparably to ibuprofen[3], but overall clinical evidence remains limited.

Brand names
ArnicareArnicamfort
Other names
Arnica montanaArnica chamissonisArnica cordifoliaArnica fulgensArnica sororiaarnica flosleopard's banemountain snuffmountain tobaccosneezewort
02

Targets

FOS (Activator Protein 1)MMP1 (Matrix metalloproteinase-1)MMP13 (Matrix metalloproteinase-13)NFAT (NFAT family)NFKB1 (NF-κB1)

Beyond the preview

Go deeper on arnica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arnica.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call